Manuel Constenla

4.0k citations
55 papers · 3.1k · 1 hit paper · h-index 19

Impact in

Papers in

    • Neutropenia and Cancer Infections 11
    • Colorectal Cancer Treatments and Studies 9
    • Cancer Treatment and Pharmacology 7
    • Lung Cancer Treatments and Mutations 12
    • Lung Cancer Diagnosis and Treatment 5
    • Gastric Cancer Management and Outcomes 5

Manuel Constenla

54 papers receiving 3.0k citations

Manuel Constenla's Hit Papers

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group 2006 · 1.5k citations
1.5k0+6+13Years since publication4008001.2k

Peers

Manuel Constenla
Comparison fields: 5 of 78
  • Pulmonary and Respiratory Medicine 1.7k
  • Gastroenterology 276
  • Oncology 1.3k
  • Otorhinolaryngology 98
  • Surgery 595
Replace J. Buesa with:
J. Buesa Spain
Heung Moon Chang South Korea
Shinya Ueda Japan
Atsuo Takashima Japan
B Paillot France
Daisuke Takahari Japan
Э К Возный Portugal
Yoshihisa Sakaguchi Japan
Francis Daniel United Kingdom
Yu Jo Chua Australia
Manuel Constenla relative to J. Buesa Spain J. Buesa's profile →
Citations per field
00.5×5.8×
J. Buesa · 1×
Citations per year

Countries citing papers authored by Manuel Constenla

Since Specialization
Citations

This map shows the geographic impact of Manuel Constenla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Constenla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Constenla more than expected).

Fields of papers citing papers by Manuel Constenla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Constenla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Constenla. The network helps show where Manuel Constenla may publish in the future.

Co-authors

The 25 scholars most cited alongside Manuel Constenla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Constenla Line = papers co-authored together Manuel Constenla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Hit paper breakdown →
20061485
2 2007213
3 2007208
4 2007158
5 2005139
6 2004112
7 2008107
8 200879
9 200559
10 200646
11 201045
12 200444
13 200442
14 200234
15 200733
16 200030
17 200425
18 201820
19 201018
20 200815

About Manuel Constenla

Manuel Constenla is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Epidemiology, having authored 55 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Neutropenia and Cancer Infections (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Gastroenterology (276 citations), Oncology (1.3k citations), Otorhinolaryngology (98 citations) and Surgery (595 citations). Manuel Constenla has collaborated with scholars based in Spain, Germany and United Kingdom. Frequent co-authors include Alejandro Majlis, Eric Van Cutsem, C. Boni, Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin, Yee Chao, Э К Возный, Adriano Rodrigues and M Fodor. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Cancer, Annals of Oncology and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact